First, they observed that in immunocompetent mice the combination of shRNA-p53 (p53 suppression) with AKT and c-Myc oncogene overexpression in the peritoneum resulted in aggressive PCa with the presence of macroscopic peritoneal implants in only 21 days. This evidence concerns the gene TP53 and posterior cortical atrophy.